-
公开(公告)号:US06924284B2
公开(公告)日:2005-08-02
申请号:US10222749
申请日:2002-08-15
申请人: Graham Beaton , Wilna J. Moree , Jaimie K. Rueter , Russell S. Dahl , David L. McElligott , Phyllis Goldman , Anthony J. Demaggio , Erik Christenson , Dan Herendeen , Kerry W. Fowler , Danwen Huang , Jaimie E. Bertino , Lisa H. Bourdon , David J. Fairfax , Qin Jiang , Helge A. Reisch , Ren Hua Song , Pavel E. Zhichkin
发明人: Graham Beaton , Wilna J. Moree , Jaimie K. Rueter , Russell S. Dahl , David L. McElligott , Phyllis Goldman , Anthony J. Demaggio , Erik Christenson , Dan Herendeen , Kerry W. Fowler , Danwen Huang , Jaimie E. Bertino , Lisa H. Bourdon , David J. Fairfax , Qin Jiang , Helge A. Reisch , Ren Hua Song , Pavel E. Zhichkin
IPC分类号: A61K31/502 , A61K31/5025 , A61K31/5377 , A61K41/00 , A61K49/00 , A61P9/00 , A61P9/10 , A61P25/00 , A61P25/14 , A61P25/16 , A61P25/28 , A61P35/00 , A61P43/00 , C07D237/32 , C07D237/34 , C07D241/44 , C07D401/12 , C07D403/12 , C07D405/12 , C07D413/12 , C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D237/52
CPC分类号: C07D401/12 , A61K41/0038 , A61K49/001 , C07D237/32 , C07D237/34 , C07D241/44 , C07D403/12 , C07D405/12 , C07D413/12 , C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04
摘要: The present invention provides compounds comprising a bicyclic aryl moiety, such as 2H-phthalazin-1-one or derivatives thereof, compositions comprising the same, and methods for producing and using the same. In particular, the present invention provides compounds of the formula: or a pharmaceutically acceptable salt, a hydrate, a solvate, or a prodrug thereof; where Q1, Q2 and Y are those defined herein.
摘要翻译: 本发明提供包含双环芳基部分的化合物,例如2H-酞嗪-1-酮或其衍生物,包含它们的组合物,及其制备和使用方法。 特别地,本发明提供下式的化合物:或其药学上可接受的盐,水合物,溶剂化物或前药; 其中Q 1,Q 2和Y是本文定义的那些。
-
公开(公告)号:US20100286279A1
公开(公告)日:2010-11-11
申请号:US12678594
申请日:2008-09-23
申请人: Helge A. Reisch , Peter Leeming , Prasad S. Raje
发明人: Helge A. Reisch , Peter Leeming , Prasad S. Raje
IPC分类号: A61K31/16 , C07C259/04 , A61P35/00 , A61P33/06 , A61P17/06
CPC分类号: C07C303/40 , C07C311/21
摘要: The present invention pertains to the general field of chemical synthesis, and more particularly to methods for the synthesis of certain hydroxamic acid compounds, and in particular, (E)-N-hydroxy-3-(3-phenylsulfamoyl-phenyl)-acrylamide, also known as PXD101 and Belinostat®, comprising, for example, the steps of: (SAF) sulfonamide formation; (PURC) optional purification; (AAA) alkenyl-acid addition, comprising: either (i): the steps of, in order: (ACAEA) alkenyl-carboxylic acid ester addition; (PURE) optional purification; and (CAD) carboxylic acid deprotection; or (ii): the step of: (ACAA) alkenyl-carboxylic acid addition; (PURF) optional purification; (HAF) hydroxamic acid formation; and (PURG) optional purification.
摘要翻译: 本发明涉及化学合成的一般领域,更具体地涉及合成某些异羟肟酸化合物,特别是(E)-N-羟基-3-(3-苯基氨磺酰基 - 苯基) - 丙烯酰胺的方法, 也称为PXD101和Belinostat,包括例如以下步骤:(SAF)磺酰胺的形成; (PURC)可选净化; (AAA)烯基酸添加,包括:(i):以下步骤:按顺序:(ACAEA)烯基 - 羧酸酯添加; (PURE)可选净化; 和(CAD)羧酸脱保护; 或(ii):步骤:(ACAA)烯基 - 羧酸添加; (PURF)可选净化; (HAF)异羟肟酸形成; 和(PURG)可选纯化。
-
公开(公告)号:US08642809B2
公开(公告)日:2014-02-04
申请号:US12678594
申请日:2008-09-23
申请人: Helge A. Reisch , Peter Leeming , Prasad S. Raje
发明人: Helge A. Reisch , Peter Leeming , Prasad S. Raje
IPC分类号: C07C303/00
CPC分类号: C07C303/40 , C07C311/21
摘要: The present invention pertains to the general field of chemical synthesis, and more particularly to methods for the synthesis of certain hydroxamic acid compounds, and in particular, (E)-N-hydroxy-3-(3-phenylsulfamoyl-phenyl)-acrylamide, also known as PXD101 and Belinostat®, comprising, for example, the steps of: (SAF) sulfonamide formation; (PURC) optional purification; (AAA) alkenyl-acid addition, comprising: either (i): the steps of, in order: (ACAEA) alkenyl-carboxylic acid ester addition; (PURE) optional purification; and (CAD) carboxylic acid deprotection; or (ii): the step of: (ACAA) alkenyl-carboxylic acid addition; (PURF) optional purification; (HAF) hydroxamic acid formation; and (PURG) optional purification.
摘要翻译: 本发明涉及化学合成的一般领域,更具体地涉及合成某些异羟肟酸化合物,特别是(E)-N-羟基-3-(3-苯基氨磺酰基 - 苯基) - 丙烯酰胺的方法, 也称为PXD101和Belinostat,包括例如以下步骤:(SAF)磺酰胺的形成; (PURC)可选净化; (AAA)烯基酸添加,包括:(i):以下步骤:按顺序:(ACAEA)烯基 - 羧酸酯添加; (PURE)可选净化; 和(CAD)羧酸脱保护; 或(ii):步骤:(ACAA)烯基 - 羧酸添加; (PURF)可选净化; (HAF)异羟肟酸形成; 和(PURG)可选纯化。
-
-